Nasopharyngeal viral load at admission is not an independent predictor of thromboembolic complications in unvaccinated COVID-19 hospitalized patientsArticle Published on 2023-02-012023-07-11 Journal: Journal of Thrombosis and Thrombolysis [Category] COVID19(2023년), [키워드] COVID-19 Dynamics SARS-CoV-2 Thromboembolism Viral load. [DOI] 10.1007/s11239-022-02762-x PMC 바로가기
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patientsArticle Published on 2022-12-012022-11-15 Journal: Annals of Medicine [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines. Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination [DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety dataReview Published on 2022-10-192023-07-10 Journal: Vaccine [Category] COVID19(2023년), [키워드] adverse event arterial Case definition COVID-19 immunization guidelines Thromboembolism thrombosis venous. [DOI] 10.1016/j.vaccine.2022.09.001 PMC 바로가기 [Article Type] Review
COVID-19 and Peripheral Artery Thrombosis: A Mini ReviewReview article Published on 2022-10-012022-10-05 Journal: Current problems in cardiology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory distress addition anticoagulant therapy Artery complex coronavirus coronavirus disease COVID-19 COVID-19 patients diagnostic disease Effect effective Health care system Hemostasis immune system management Manifestations MINI morbidity Mortality pandemic pathophysiology Patient patients patients with COVID-19 peripheral reported reveal review syndrome Thrombectomy Thromboembolism Thromboprophylaxis thrombosis thrombotic event Treatment venous while [DOI] 10.1016/j.cpcardiol.2021.100992 [Article Type] Review article
Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied CaseArticle Published on 2022-09-292022-11-15 Journal: Medicina [Category] SARS, 진단, [키워드] ACE-2 receptor anabolic anabolic androgenic steroids androgenic steroid atherosclerotic plaques Autopsy COVID-19 death Diffuse alveolar damage Endothelitis form Genetic Genetic predisposition histopathological HLA allele immune system Infection kidneys liver lung male microthrombi Myocardial infarction Myocardium organs pancreas Patient positive Pulmonary edema risk risk factor SARS-CoV-2 SARS-CoV-2 RT-PCR test spleen steroid Testosterone. Thromboembolism tissue [DOI] 10.3390/medicina58101373 PMC 바로가기
The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factorsArticle Published on 2022-09-282022-11-15 Journal: Frontiers in Immunology [Category] 치료제, [키워드] activate activating addition aggregation antiplatelet Blood coagulation factor complex convalescent COVID-19 COVID-19 patients disease severity disorders endothelial injury Factor Gas exchange hypercoagulability hypercoagulable hypercoagulable states Hypoxemia hypoxia immune cells impaired lung function impairment incidence Inflammation Inflammatory mediators inhibiting Intervention intrinsic involved Lung function manifestation marker microvesicle Microvesicles Mild Mortality Phosphatidylserine Platelet platelet activation Platelets promote PROTECT pulmonary permeability pulmonary vasculitis reactivity reducing resulting risk severe cases stages the disease therapy Thromboembolism thrombosis thrombosis. thrombotic event tissue Treatment vessel walls with COVID-19 [DOI] 10.3389/fimmu.2022.955654 PMC 바로가기
SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesisSARS-CoV-2 감염 유발 성장 인자는 COVID-19 발병 기전에서 다른 역할을 합니다Article Published on 2022-09-012022-09-11 Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 치료기술, [키워드] adverse effect adverse effects angiopoietin association COVID-19 COVID-19 pathogenesis COVID-19 patient Critical Critically ill cytokine Cytokine storm Cytokine storms Cytokines D-dimer disease dysregulation EGF elevated Endothelial dysfunction EPO erythropoietin exhibited G-CSF growth factor Growth factors HGF Hospitalized ICU Inflammation Injury inverse correlation investigation marker moderate Myoglobin negative correlation non-ICU occur P-selectin Pathogenesis pathogenesis of COVID-19 pathophysiology PDGF plasma positive correlation reflected remained repair SARS-COV-2 infection selectin specific disease Thromboembolism tissue tissue injury Tissue injury. upregulated vague VEGF was performed [DOI] 10.1016/j.lfs.2022.120703 PMC 바로가기 [Article Type] Article
SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19SARS-CoV-2 감염은 COVID-19의 초기 중등도 단계에서 가용성 혈소판 활성화 마커 및 PAI-1을 유도합니다Article Published on 2022-08-012022-09-11 Journal: International journal of laboratory hematology [Category] MERS, SARS, 바이오마커, [키워드] activated activated partial thromboplastin time activation of platelet activation of platelets Analysis aPTT CD40 ligand Coagulation coagulation dysfunction coagulation factor Coagulation factors Coagulation system coagulation test coagulation tests Comorbidity correlated COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity D-dimer dysfunction dysregulated elevated Factor fibrinogen flow cytometry FXIII help hospitalized COVID-19 patient hospitalized COVID-19 patients induce inhibitor intensive care limit marker moderate Moderate COVID-19 molecular Multiplex assay P-selectin partial thromboplastin time Pathogenesis pathogenesis of COVID-19 pathway performed plasma plasminogen Platelet platelet activation Platelets Pneumonia progression prothrombin Prothrombin time recruited reduction in required SARS-COV-2 infection severe cases severe COVID-19 severe patients severity significantly Stage TFPI the disease Thromboembolism THROMBOPLASTIN Thromboprophylaxis tissue Tissue Factor tissue factor pathway inhibitor tissue plasminogen activator tissue plasminogen activator. [DOI] 10.1111/ijlh.13829 PMC 바로가기 [Article Type] Article
A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infectionReview article Published on 2022-08-012022-10-05 Journal: IJC Heart & Vasculature [Category] 바이오마커, 임상, 진단, 치료법, [키워드] abnormality absence Anticoagulant anticoagulation antithrombotic therapy Clinical outcome Coagulation Coagulopathy Consensus contraindication coronavirus COVID-19 COVID-19 patients COVID19 patients Critical Developing Diagnosis diagnosis of COVID-19 discharge Factor Guidance high risk hospitalized COVID-19 hospitalized patients increase in Infection Inflammation information intensity morbidity Mortality Myocardial pathophysiological mechanism Patient patients patients hospitalized prescribing Prophylactic randomized trial risk severe COVID-19 severe COVID-19 disease similarity stroke subject Thromboembolism thrombosis Thrombotic complications Treatment Venous Thromboembolism with COVID-19 [DOI] 10.1016/j.ijcha.2022.101068 [Article Type] Review article
Cardiopulmonary Imaging Utilization and Findings among Hospitalized COVID-19 Patients in Latin America: (From “RIMAC: Registry IMAging Cardiopulmonary among Hospitalized COVID-19 Patients in LATAM”)Observational Study Published on 2022-08-012022-10-04 Journal: Global Heart [Category] SARS, 임상, [키워드] Admission America association Cardiopulmonary Cardiopulmonary Images carried Chest CT Comorbidities Comorbidity complications conducted COVID-19 COVID-19 hospitalization diabetes Diagnosis discharge Evolution finding ground glass heart highest Hospitalization hospitalized patient hypertension ICU imaging In-hospital death in-hospital mortality information Inpatients interstitial lack LATAM Latin Latin America lung magnetic resonance imaging males median age Myocardial infarction nine pandemic performed predominant prevalent Prognosis Region regions registry RIMAC SARS-CoV-2 SARS-CoV-2. severity South America syndrome the SARS-CoV-2 Thromboembolism utilization X-ray [DOI] 10.5334/gh.1134 PMC 바로가기 [Article Type] Observational Study